• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6,7-二羟基-2-二甲基氨基四氢萘、N-正丙基-3-(3-羟基苯基)哌啶、N-正丙基去甲阿扑吗啡和培高利特作为纹状体多巴胺自身受体和突触后多巴胺受体激动剂的相对选择性。

Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.

作者信息

Claustre Y, Fage D, Zivkovic B, Scatton B

出版信息

J Pharmacol Exp Ther. 1985 Feb;232(2):519-25.

PMID:2857197
Abstract

6,7-Dihydroxy-2-dimethylaminotetralin (TL-99), N-n-propyl-3-(3-hydroxyphenylpiperidine [(+/-)-3-PPP], N-n-propylnorapomorphine and pergolide were evaluated for activity on a number of biochemical parameters that are presumed to indicate an agonist effect at dopamine (DA) autoreceptors (antagonism of the gamma-hydroxybutyrate-induced increase in dopa formation), at postsynaptic DA receptors (elevation of acetylcholine levels) or at both types of DA receptors (diminution of DA synthesis and homovanillic acid levels) in rat striatum. All four agents decreased striatal dopa accumulation (in the presence and in the absence of gamma-hydroxybutyrate). N-propylnorapomorphine, pergolide and TL-99 also reduced homovanillic acid levels and increased acetylcholine concentrations in striatum whereas (+/-)-3-PPP was inactive. The compounds were all more potent in diminishing dopa accumulation caused by gamma-hydroxybutyrate treatment than in increasing acetylcholine levels [(+/-)-3-PPP showing the highest dissociation] indicating a preferential agonist activity at DA autoreceptors. The relative selectivity of the compounds for DA autoreceptors and postsynaptic DA receptors was evaluated further by studying the antagonism by these drugs of the activation of striatal dopa formation (index of both DA autoreceptor and postsynaptic DA receptor stimulation) and tyrosine hydroxylase (index of postsynaptic DA receptor stimulation only) induced by haloperidol or reserpine. The DA agonists were all more potent in antagonizing the neuroleptic-induced increase in DA synthesis than in counteracting the drug-induced activation of tyrosine hydroxylase, with (+/-)-3PPP exhibiting the highest dissociation. The present results indicate that the DA agonists studied possess some selectivity for striatal DA autoreceptors, (+/-)-3-PPP being the most selective in this respect.

摘要

对6,7-二羟基-2-二甲基氨基四氢萘(TL-99)、N-正丙基-3-(3-羟基苯基)哌啶[(±)-3-PPP]、N-正丙基去甲阿扑吗啡和培高利特进行了评估,观察它们对一些生化参数的作用,这些参数被认为可表明其对大鼠纹状体中多巴胺(DA)自身受体(拮抗γ-羟基丁酸诱导的多巴形成增加)、突触后DA受体(乙酰胆碱水平升高)或两种类型DA受体(DA合成和高香草酸水平降低)的激动剂效应。所有这四种药物均降低了纹状体中的多巴积累(无论有无γ-羟基丁酸)。N-正丙基去甲阿扑吗啡、培高利特和TL-99还降低了纹状体中的高香草酸水平并增加了乙酰胆碱浓度,而(±)-3-PPP则无活性。这些化合物在减少γ-羟基丁酸处理引起的多巴积累方面比增加乙酰胆碱水平更有效[(±)-3-PPP表现出最大的差异],表明其对DA自身受体具有优先激动剂活性。通过研究这些药物对氟哌啶醇或利血平诱导的纹状体多巴形成激活(DA自身受体和突触后DA受体刺激的指标)和酪氨酸羟化酶(仅突触后DA受体刺激的指标)的拮抗作用,进一步评估了这些化合物对DA自身受体和突触后DA受体的相对选择性。这些DA激动剂在拮抗抗精神病药物诱导的DA合成增加方面比抵消药物诱导的酪氨酸羟化酶激活更有效,(±)-3PPP表现出最大的差异。目前的结果表明,所研究的DA激动剂对纹状体DA自身受体具有一定的选择性,(±)-3-PPP在这方面是最具选择性的。

相似文献

1
Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.6,7-二羟基-2-二甲基氨基四氢萘、N-正丙基-3-(3-羟基苯基)哌啶、N-正丙基去甲阿扑吗啡和培高利特作为纹状体多巴胺自身受体和突触后多巴胺受体激动剂的相对选择性。
J Pharmacol Exp Ther. 1985 Feb;232(2):519-25.
2
Relationship between receptor occupancy and response at striatal dopamine autoreceptors.纹状体多巴胺自身受体的受体占有率与反应之间的关系。
Mol Pharmacol. 1987 Jun;31(6):592-8.
3
Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.3-PPP对映体在纹状体多巴胺自身受体上的差异激动剂特征:对细胞外多巴胺的依赖性。
Synapse. 1991 Jul;8(3):169-76. doi: 10.1002/syn.890080304.
4
Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.对映体单羟基和二羟基阿朴啡对大鼠纹状体组织中多巴胺合成的突触前抑制作用。
Mol Pharmacol. 1990 Jul;38(1):92-101.
5
A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
J Pharmacol Exp Ther. 1982 Nov;223(2):298-304.
6
Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.纹状体多巴胺D2受体激动剂结构要求的进一步表征及其与纹状体多巴胺D1受体激动剂结构要求的比较。用一系列单羟基氨基四氢萘对大鼠纹状体乙酰胆碱释放的研究。
Mol Pharmacol. 1984 Nov;26(3):452-7.
7
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.CI - 1007,一种多巴胺部分激动剂及潜在的抗精神病药物。I. 神经化学效应。
J Pharmacol Exp Ther. 1995 Aug;274(2):898-911.
8
Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.假定的多巴胺自身受体激动剂3-PPP和TL-99的药理学特征。
Eur J Pharmacol. 1981 Nov 19;76(1):15-23. doi: 10.1016/0014-2999(81)90004-2.
9
Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
J Pharmacol Exp Ther. 1984 Jun;229(3):706-11.
10
Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.内侧前额叶皮质中多巴胺合成的调节由释放调节自身受体介导:体内研究
J Pharmacol Exp Ther. 1986 Mar;236(3):689-98.

引用本文的文献

1
Kinetic properties of the in vivo accumulation of 3H-(-)-N-n-propylnorapomorphine in mouse brain.3H-(-)-N-正丙基去甲阿朴吗啡在小鼠脑内的体内蓄积动力学特性。
Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):13-20. doi: 10.1007/BF00169200.
2
Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease.培高利特。其药理特性及在帕金森病中的治疗潜力综述。
Drugs. 1990 Mar;39(3):491-506. doi: 10.2165/00003495-199039030-00009.
3
Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques.
J Neural Transm Gen Sect. 1990;80(1):33-50. doi: 10.1007/BF01245021.